Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition

It has been uncertain whether specific disease-relevant biomarker phenotypes can be found using sporadic Parkinson’s disease (PD) patient-derived samples, as it has been proposed that there may be a plethora of underlying causes and pathological mechanisms. Fibroblasts derived from familial PD patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, G. A., Jansson, J., Rocha, E. M., Osborn, T., Hallett, P. J., Isacson, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012155/
https://www.ncbi.nlm.nih.gov/pubmed/26399642
http://dx.doi.org/10.1007/s12035-015-9435-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012155/
https://www.ncbi.nlm.nih.gov/pubmed/26399642
http://dx.doi.org/10.1007/s12035-015-9435-4

Ejemplares similares